UPLYFT For Lymphoma Survivors
An Intervention for Fear of Cancer Recurrence for Lymphoma Survivors
Dana-Farber Cancer Institute
74 participants
Feb 8, 2022
INTERVENTIONAL
Conditions
Summary
The main purpose of this study is to field test and pilot an intervention called UPLYFT (Understand and Prevail: Lymphoma Fear of Recurrence Therapy) that includes information about lymphoma survivorship and tools to improve quality of life and reduce lymphoma-related worries among lymphoma survivors.
Eligibility
Inclusion Criteria10
- Lymphoma Survivors Phase 1 and 2:
- Diagnosis of lymphoma (indolent non-Hodgkin lymphoma, aggressive non-Hodgkin lymphoma, or classic Hodgkin lymphoma)
- Age ≥ 18 years
- Interval of 3 months to 24 months from completion of first-line treatment
- In complete remission after first line of treatment
- Clinically significant FCR (score of ≥ 16 on the validated FCR Inventory-Severity Subscale \[FCRI-SS).
- Access to computer (for videoconferencing)
- Lymphoma clinicians and mental health clinicians Phase 1:
- Lymphoma clinicians ≥ 1 year from oncology fellowship completion OR mental health clinicians (psychologists, social workers, psychiatrists) ≥ 1 year from completion of clinical training.
- Longitudinal clinical care for patients with lymphoma by oncologists OR provision of care for patients with cancer by mental health clinicians
Exclusion Criteria13
- Lymphoma Survivors Phase 1:
- Age \< 18 years
- Concurrent other malignancy
- Patients with uncontrolled/untreated psychotic disorders or untreated bipolar and borderline personality disorder (as ascertained from medical record screen).
- Lymphoma Survivors Phase 2:
- Age \< 18 years
- Concurrent other malignancy
- Patients with uncontrolled/untreated psychotic disorders or untreated bipolar and borderline personality disorders (as ascertained from medical record screen).
- Our study will exclude members of the following special populations:
- Adults unable to consent
- Individuals who are not yet adults (infants, children, teenagers)
- Pregnant women
- Prisoners
Interventions
One time, qualitative interview of clinicians for feedback on UPLYFT intervention
6 session of UPLYFT intervention with Lymphoma Survivors for feedback
6 session of UPLYFT intervention with Lymphoma Survivors
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05080166